These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23111887)

  • 1. Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature.
    Kukoyi A; Coker S; Lewis L; Nierenberg D
    Hum Exp Toxicol; 2013 Jan; 32(1):107-10. PubMed ID: 23111887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients.
    Baddigam K; Russo P; Russo J; Tobias JD
    J Intensive Care Med; 2005; 20(2):118-23. PubMed ID: 15855224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectivness of Clonidine in Treating Dexmedetomidine Withdrawal in a Patient with Co-Existing Psychiatric Illness: A Case Report.
    Mohamed A; Mahmoud S; Saad MO; Gazwi K; Elshafei M; Al Anany R
    Am J Case Rep; 2018 Jul; 19():875-879. PubMed ID: 30046031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal.
    Mueller SW; Preslaski CR; Kiser TH; Fish DN; Lavelle JC; Malkoski SP; MacLaren R
    Crit Care Med; 2014 May; 42(5):1131-9. PubMed ID: 24351375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence and predictors of dexmedetomidine infusion intolerance and failure.
    Tellor BR; Arnold HM; Micek ST; Kollef MH
    Hosp Pract (1995); 2012 Feb; 40(1):186-92. PubMed ID: 22406894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of dexmedetomidine for prevention of withdrawal syndrome in the pediatric intensive care unit: protocol for an adaptive, multicenter, randomized, double-blind, placebo-controlled, non-profit clinical trial.
    Mondardini MC; Sperotto F; Daverio M; Caramelli F; Gregori D; Caligiuri MF; Vitale F; Cecini MT; Piastra M; Mancino A; Pettenazzo A; Conti G; Amigoni A
    Trials; 2019 Dec; 20(1):710. PubMed ID: 31829274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous dexmedetomidine infusions to treat or prevent drug withdrawal in infants and children.
    Tobias JD
    J Opioid Manag; 2008; 4(4):187-91. PubMed ID: 18837201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal.
    Multz AS
    Anesth Analg; 2003 Apr; 96(4):1054-1055. PubMed ID: 12651659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Patients with Alcohol Withdrawal Syndrome Treated with High-Dose Sedatives and Deferred Intubation.
    Stewart R; Perez R; Musial B; Lukens C; Adjepong YA; Manthous CA
    Ann Am Thorac Soc; 2016 Feb; 13(2):248-52. PubMed ID: 26799430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition from dexmedetomidine to enteral clonidine for ICU sedation: an observational pilot study.
    Gagnon DJ; Riker RR; Glisic EK; Kelner A; Perrey HM; Fraser GL
    Pharmacotherapy; 2015 Mar; 35(3):251-9. PubMed ID: 25809176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients.
    Frazee EN; Personett HA; Leung JG; Nelson S; Dierkhising RA; Bauer PR
    J Crit Care; 2014 Apr; 29(2):298-302. PubMed ID: 24360597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Propofol Plus Dexmedetomidine in Patients Experiencing Severe Alcohol Withdrawal in the Intensive Care Unit.
    Love K; Zimmermann AE
    J Clin Pharmacol; 2020 Apr; 60(4):439-443. PubMed ID: 31663139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal from multiple sedative agent therapy in an infant: is dexmedetomidine the cause or the cure?
    Darnell C; Steiner J; Szmuk P; Sheeran P
    Pediatr Crit Care Med; 2010 Jan; 11(1):e1-3. PubMed ID: 20051785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit.
    Arpino PA; Kalafatas K; Thompson BT
    J Clin Pharm Ther; 2008 Feb; 33(1):25-30. PubMed ID: 18211613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of dexmedetomidine in the pediatric intensive care unit.
    Buck ML; Willson DF
    Pharmacotherapy; 2008 Jan; 28(1):51-7. PubMed ID: 18154474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease*.
    Gupta P; Whiteside W; Sabati A; Tesoro TM; Gossett JM; Tobias JD; Roth SJ
    Pediatr Crit Care Med; 2012 Nov; 13(6):660-6. PubMed ID: 22791093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid and benzodiazepine withdrawal syndrome in adult burn patients.
    Brown C; Albrecht R; Pettit H; McFadden T; Schermer C
    Am Surg; 2000 Apr; 66(4):367-70; discussion 370-1. PubMed ID: 10776874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery?
    Chrysostomou C; Sanchez De Toledo J; Avolio T; Motoa MV; Berry D; Morell VO; Orr R; Munoz R
    Pediatr Crit Care Med; 2009 Nov; 10(6):654-60. PubMed ID: 19295456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal.
    Darrouj J; Puri N; Prince E; Lomonaco A; Spevetz A; Gerber DR
    Ann Pharmacother; 2008 Nov; 42(11):1703-5. PubMed ID: 18780809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: case report and review of the literature.
    Gerlach AT; Murphy CV
    Pharmacotherapy; 2009 Dec; 29(12):1492. PubMed ID: 19947809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.